For example, RAD51C c.837 + 1G > A results in exon 5 skipping (Pelttari et al., 2011) with a different variant resulting in exon 6 skipping (Meindl et al., 2010), and a novel pathogenic splice‐site RAD51C variant at the last nucleotide of exon 2 (c.404G > C/T) in BC and OC patients in families (Neidhardt et al., 2017). Here, RAD51C is linked to breast cancer.